Neuronotrophic and neurite-promoting factors and their clinical potentials
- PMID: 6088207
- DOI: 10.1159/000112334
Neuronotrophic and neurite-promoting factors and their clinical potentials
Abstract
Neuronal maintenance and neuritic growth during development are increasingly recognized as being under the extrinsic control of neuronotrophic- and neurite-promoting agents. Protein agents ('factors') are the most studied but not the only molecules exerting such controls. It appears increasingly likely that adult neurons in situ are equally subject to similar extrinsic regulations. Two recently studied in vivo models for peripheral and central neural regeneration have demonstrated trauma-related accumulations of neuronotrophic- and neurite-promoting factors in the adult rat, in close temporal correlation with neuronal maintenance and axonal regrowth, respectively. Deficits in the supply or utilization of similar factors may underlie neuronal or glial regressive processes in aging, and in selected neuronal diseases such as Parkinson, ALS and Alzheimer. Speculative approaches to, and potential problems of, clinical interventions addressing putative neuronotrophic deficits are discussed.
Similar articles
-
Cholinergic neuronotrophic factors: I. Survival, neurite outgrowth and choline acetyltransferase activity in monolayer cultures from chick embryo ciliary ganglia.Brain Res. 1979 Sep 7;173(1):29-45. doi: 10.1016/0006-8993(79)91093-x. Brain Res. 1979. PMID: 487083
-
Neuronotrophic activities accumulate in vivo within silicone nerve regeneration chambers.Brain Res. 1983 Feb 14;261(1):109-16. doi: 10.1016/0006-8993(83)91289-1. Brain Res. 1983. PMID: 6839146 No abstract available.
-
The nerve growth factor-target cells interaction: a model system for the study of directed axonal growth and regeneration.Birth Defects Orig Artic Ser. 1983;19(4):3-22. Birth Defects Orig Artic Ser. 1983. PMID: 6871400 No abstract available.
-
Biology of gangliosides: neuritogenic and neuronotrophic properties.J Neurosci Res. 1984;12(2-3):147-59. doi: 10.1002/jnr.490120204. J Neurosci Res. 1984. PMID: 6389895 Review.
-
The role of nerve growth factor in the pathogenesis and therapy of diabetic neuropathy.Diabet Med. 1993;10 Suppl 2:10S-13S. doi: 10.1111/j.1464-5491.1993.tb00189.x. Diabet Med. 1993. PMID: 8334833 Review. No abstract available.
Cited by
-
Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance.Mol Neurobiol. 2023 Aug;60(8):4206-4231. doi: 10.1007/s12035-023-03328-5. Epub 2023 Apr 13. Mol Neurobiol. 2023. PMID: 37052791 Review.
-
Peroxidative block of glucose utilization and survival in CNS neuronal cultures.Neurochem Res. 1988 Jul;13(7):611-6. doi: 10.1007/BF00973276. Neurochem Res. 1988. PMID: 2901050
-
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes.J Virol. 1991 Mar;65(3):1370-6. doi: 10.1128/JVI.65.3.1370-1376.1991. J Virol. 1991. PMID: 1704927 Free PMC article.
-
Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9231-5. doi: 10.1073/pnas.83.23.9231. Proc Natl Acad Sci U S A. 1986. PMID: 3466184 Free PMC article.
-
Examination of a nerve injury-induced, 37 kDa protein: purification and characterization.Neurochem Res. 1987 Oct;12(10):967-76. doi: 10.1007/BF00966320. Neurochem Res. 1987. PMID: 3683743
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous